参考文献/References:
[1] JONESR M,NEISH A S.Gut microbiota in intestinal and liver disease[J].Annu Rev Pathol,2021,16:251-275.
[2] DOIFODE T,GIRIDHARAN V V,GENEROSO J S,et al.The impact of the microbiota-gut-brain axis on Alzheimer's disease pathophysiology[J].Pharmacol Res,2021,164:105314.
[3] LORENZO J.From the gut to bone: connecting the gut microbiota with Th17 T lymphocytes and postmenopausal osteoporosis[J].J Clin Invest,2021,131(5):e146619.
[4] CHENG M,TAN B,WU X,et al.Gut microbiota is involved in alcohol-induced osteoporosis in young and old rats through immune regulation[J].Front Cell Infect Microbiol,2021,11:636231.
[5] MEI F,MENG K,GU Z,et al.Arecanut(Areca catechu L.)seed polyphenol-ameliorated osteoporosis by altering gut microbiome via LYZ and the immune system in estrogen-deficient rats[J].J Agric Food Chem,2021,69(1):246-258.
[6] KHAIRALLAH P,NICKOLAS T.Bone and mineral disease in kidney transplant recipients[J].Clin J Am Soc Nephrol,2022,17(1):121-130.
[7] HUANG J F,ZHENG X Q,SUN X L,et al.Association between bone mineral density and severity of chronic kidney disease[J/OL].Int J Endocrinol,2020[2022-02-01].https://pubmed.ncbi.nlm.nih.gov/33193760.
[8] 乔小万,邓强,李中锋,等.基于“肾虚髓枯”理论探讨骨质疏松症的病机及中药治疗[J].中国骨质疏松杂志,2022,28(5):760-765.
[9] 张博,李炎,黄树明.“肾通于脑”理论的科学实质探析[J].辽宁中医杂志,2022,49(1):62-64.
[10] 李慧,何晓娟,贾良良,等.肾主骨生髓与膝骨关节炎筋骨失养的关系[J].风湿病与关节炎,2019,8(2):48-51.
[11] 张骞予,杨鸫祥,楼家晖.补肾中药诱导骨髓间充质干细胞增殖分化防治骨质疏松的研究进展[J].中华中医药学刊,2020,38(3):193-195.
[12] WEI Q,WANG B,HU H,et al.Icaritin promotes the osteogenesis of bone marrow mesenchymal stem cells via the regulation of sclerostin expression[J].Int J Mol Med,2020,45(3):816-824.
[13] 郭澜,李莉,葛继荣.从外泌体探讨“肾主骨生髓”理论与骨质疏松症的关系[J].中国骨质疏松杂志,2020,26(12):1852-1856.
[14] 尚奇,任辉,沈耿杨,等.基于肾主骨生髓理论探讨老年性骨质疏松症的中医治疗[J].中医杂志,2017,58(16):1433-1435.
[15] TROMBETTI A,STOERMANN C,CHEVALLEY T,et al.Alterations of bone microstructure and strength in end-stage renal failure[J].Osteoporos Int,2013,24(5):1721-1732.
[16] NICKOLAS T L,STEIN E,COHEN A,et al.Bone mass and microarchitecture in CKD patients with fracture[J].J Am Soc Nephrol,2010,21(8):1371-1380.
[17] 张也,郭亚雄,罗世杰,等.基于中医脾肾-脑相通理论浅谈孤独症谱系障碍[J].河南中医,2021,41(1):20-23.
[18] 蔡光先,刘柏炎.从干细胞分化研究“肾通于脑”的策略[J].湖南中医学院学报,2004,24(1):30-31.
[19] 张景欣,王智,马明.杜仲对骨髓间充质干细胞增殖和向神经元分化的影响[J].世界中西医结合杂志,2016,11(7):945-948.
[20] 许云腾,李西海.从肾-脑-骨轴初探绝经后骨质疏松骨内稳态失衡的机制[J].中华中医药杂志,2020,35(10):4797-4800.
[21] KELLY R R,SIDLES S J,LARUE A C,et al.Effects of neurological disorders on bone health[J].Front Psycho,2020,11:612366.
[22] OTTO E,KNAPSTEIN P R,JAHN D,et al.Crosstalk of brain and bone-clinical observations and their molecular bases[J].Int J Mol Sci,2020,21(14):4946.
[23] 赵鑫,王珊珊,赵楠楠,等.补肾益髓汤联合针刺对脑梗死后轻度认知障碍认知功能改善、脑血流动力学及脑红蛋白水平影响[J].辽宁中医药大学学报,2022,24(2):140-144.
[24] 马祥雪,王凤云,符竣杰,等.基于肠道菌群的中医健脾方剂作用机制的研究现状与思考[J].中国实验方剂学杂志,2017,23(5):210-215.
[25] 朱文芳,孙克伟,陈斌,等.乙型肝炎相关性肝衰竭不同黄疸证的肠道菌群分析[J].湖南中医药大学学报,2013,33(1):128-131.
[26] 于海洋,王志勇,汪海燕,等.基于“肠道微生态”谈中医学从“脾”论治骨质疏松症的科学内涵[J].中国骨质疏松杂志,2021,27(3):459-462.
[27] MEIJERS B K I,EVENEPOEL P.The gut-kidney axis:indoxyl sulfate,p-cresyl sulfate and CKD progression[J].Nephrol Dial Transplant,2011,26(3):759-761.
[28] RAMOS C I,ARMANI R G,CANZIANI M E F,et al.Effect of prebiotic(fructooligosaccharide)on uremic toxins of chronic kidney disease patients:a randomized controlled trial[J].Nephrol Dial Transplant,2019,34(11):1876-1884.
[29] ZHANG W,MIIKEDA A,ZUCKERMAN J,et al.Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice[J].Sci Rep,2021,11(1):518.
[30] 邹川,吴禹池,杨丽虹,等.结合肠肾轴理论探讨中医药从结肠治疗慢性肾脏病的研究思路[J].世界科学技术-中医药现代化,2013,15(5):947-951.
[31] 李雅方,梁瑞琼,邱鸿钟.中西医关于菌-肠-脑轴与失眠关联机制的探讨[J].世界科学技术-中医药现代化,2020,22(7):2494-2498.
[32] MORAIS L H,SCHREIBER H L 4th.The gut microbiota-brain axis in behaviour and brain disorders[J].Nat Rev Microbiol,2021,19(4):241-255.
[33] CRYAN J F,O'RIORDAN K J,COWAN C S M,et al.The Microbiota-Gut-Brain Axis[J].Physiol Rev,2019,99(4):1877-2013.
[34] WALLIMANN A,MAGRATH W,THOMPSON K,et al.Gut microbial-derived short-chain fatty acids and bone:a potential role in fracture healing[J].Eur Cell Mater,2021,41:454-470.
[35] 张倩璐,江婷,赵国军.脂多糖抑制成骨细胞分化作用研究[J].中国临床药理学杂志,2019,35(21):2743-2746.
[36] WANG Z,YU Y,LIAO J,et al.S-Propargyl-Cysteine remodels the gut microbiota to alleviate rheumatoid arthritis by regulating bile acid metabolism[J].Front Cell Infect Microbiol,2021,11:670593.
[37] WHISNER C M,MARTIN B R,NAKATSU C H,et al.Soluble maize fibre affects short-term calcium absorption in adolescent boys and girls:a randomised controlled trial using dual stable isotopic tracers[J].Br J Nutr,2014,112(3):446-456.
[38] ROSHCHINA V V.New trends and perspectives in the evolution of neurotransmitters in microbial, plant, and animal cells[J].Adv Exp Med Biol,2016,874:25-77.
[39] YUAN S,SHEN J.Bacteroides vulgatus diminishes colonic microbiota dysbiosis ameliorating lumbar bone loss in ovariectomized mice[J].Bone,2021,142:115710.
[40] YANO J M,YU K,DONALDSON G P,et al.Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis[J].Cell,2015,161(2):264-276.
[41] 江孝龙,蒋国华.老年骨质疏松患者血清瘦素、胰岛素样生长因子-Ⅰ、组织蛋白酶K和氧化应激指标的水平及意义[J].中国老年学杂志,2018,38(12):2954-2956.
[42] ZHANGB,YANG L,ZENG Z,et al.Leptin potentiates bmp9-induced osteogenic differentiation of mesenchymal stem cells through the activation of jak/stat signaling[J].Stem Cells Dev,2020,29(8):498-510.
[43] 黄宏兴,吴青,李跃华,等.肌肉、骨骼与骨质疏松专家共识[J].中国骨质疏松杂志,2016,22(10):1221-1229.
[44] 张文达,胡美思,任艳玲.基于AMPK/mTOR信号通路探讨左、右归丸对绝经后骨质疏松症大鼠骨吸收的影响[J].中华中医药杂志,2021,36(3):1379-1383.
[45] 周强.左归丸对骨质疏松症大鼠骨、肾、下丘脑GPR48、CREB、BMP9影响的实验研究[D].沈阳:辽宁中医药大学,2016.
[46] 姜坤.右归丸对骨质疏松症大鼠骨、肾、下丘脑PKA、CREB及ATF4蛋白表达的影响[D].沈阳:辽宁中医药大学,2016.
[47] 肖丽,龙抗胜,薛智慧,等.电针对去势大鼠骨密度及下丘脑中瘦素与瘦素受体的影响[J].时珍国医国药,2016,27(8):2031-2033.
[48] 胡栢均,吴宇峰.伍中庆教授归脾汤治疗骨质疏松症的经验[J].光明中医,2011,26(6):1102-1104.
[49] 王翔,赵咏芳,石印玉,等.健脾方对去势大鼠维生素D代谢的影响[J].中国骨质疏松杂志,2007,13(6):429-432.
[50] 孔源,宫云昭,王莹,等.补肾健脾方对去卵巢诱导大鼠骨质疏松的作用及其机制研究[J].中华中医药学刊,2021,39(8):175-179.
[51] SCHEPPER J D,COLLINS F,RIOS-ARCE N D,et al.Involvement of the gut microbiota and barrier function in glucocorticoid-induced osteoporosis[J].J Bone Miner Res,2020,35(4):801-820.
[52] LIU H,GU R,LI W,et al.Lactobacillus rhamnosus GG attenuates tenofovir disoproxil fumarate-induced bone loss in male mice via gut-microbiota-dependent anti-inflammation[J].Ther Adv Chronic Dis,2019,10:2040.
[53] 王聪聪,龚敏,王立红,等.补肾健脾活血汤联合西医常规疗法治疗糖尿病骨质疏松症临床研究[J].国际中医中药杂志,2020,42(10):955-959.
[54] 颜春鲁,安方玉,汪永锋,等.右归丸对大鼠膝骨关节炎的干预作用及其机制[J].中国应用生理学杂志,2020,36(5):511-516.
[55] 马成.六味地黄汤加味治疗老年膝骨关节炎(肝肾阴虚证)的临床观察[D].长沙:湖南中医药大学,2020.
[56] 蔡玉梅,黄文燕,郑继范,等.从脾胃论治膝骨关节炎的临床研究[J].针灸临床杂志,2011,27(3):28-29.
[57] HUANG Z Y,CHEN J,LI B L,et al.Faecal microbiota transplantation from metabolically compromised human donors accelerates osteoarthritis in mice[J].Annals of the rheumatic diseases,2020,79(5):646-656.
[58] 卢耀鸣,郭达,卢晓敏,等.中国广东地区膝骨关节炎患者与健康人群肠道菌群差异性分析[J].中国骨质疏松杂志,2020,26(11):1679-1684.
[59] 马秉楠,关玉波,陈长锋,等.补肾生髓强骨方对酒精性股骨头坏死模型大鼠炎症因子、氧化应激及TLR4、NF-κB和VEGF蛋白表达的影响[J].中国中医急症,2020,29(12):2125-2128.
[60] 李中峰,陈明海,凡一诺,等.右归饮治疗激素性股骨头坏死作用机制的网络药理学分析[J].中国组织工程研究,2021,25(8):1256-1263.
[61] 刘锌,杜斌,高丽丽,等.右归饮干预激素性股骨头坏死大鼠骨髓间充质干细胞的自噬及命运[J].中国组织工程研究,2021,25(1):20-25.
[62] 刘锌,金翔,杜斌,等.右归饮加减方对兔激素性股骨头坏死的干预作用及其机制研究[J].江苏中医药,2019,51(9):81-85.
[63] 张申尧.补肾健脾通络方辅治激素性股骨头坏死临床观察[J].实用中医药杂志,2019,35(7):841-842.
[64] 李涛,李秋梅,董玉娟.健脾补肾通络方结合银质针治疗股骨头缺血性坏死的临床观察[J].宁夏医学杂志,2020,42(6):560-562.
[65] GURWARA S,DAI A,AJAMI N J,et al.Alcohol use alters the colonic mucosa-associated gut microbiota in humans[J].Nutr Res,2020,83:119-128.
[66] BLUEMEL S,WANG L,KUELBS C,et al.Intestinal and hepatic microbiota changes associated with chronic ethanol administration in mice[J].Gut Microbes,2020,11(3):265-275.
[67] 陆万里,李同林,卞恒杰,等.血清瘦素、骨保护素与特发性股骨头坏死相关性研究[J].中国医药科学,2020,10(21):18-22.
[68] QUEIPO-ORTUÑO M I,SEOANE L M,MURRI M,et al.Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels[J].PLoS One,2013,8(5):e65465.
[69] 周丽华.穴位按摩联合音乐疗法对股骨头坏死患者心理状态及生活质量的影响[J].中外医学研究,2019,17(28):175-177.